A detailed history of Stonegate Management LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Stonegate Management LLC holds 6,500 shares of AZN stock, worth $579,150. This represents 0.33% of its overall portfolio holdings.

Number of Shares
6,500
Holding current value
$579,150
% of portfolio
0.33%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 13, 2025

BUY
$68.72 - $82.11 $446,680 - $533,715
6,500 New
6,500 $499 Million

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $276B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Stonegate Management LLC Portfolio

Follow Stonegate Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stonegate Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stonegate Management LLC with notifications on news.